US bans genetic discrimination
But issue not closed
The US has banned genetic discrimination by health insurers and employers. The Genetic Information Nondiscrimination Act, which sailed through both the House (414-1) and the Senate (95-0), prohibits health insurance companies from using genetic information to deny benefits or raise premiums. "This clears away what in many people´s mind had been a real cloud on the horizon," says Dr Francis S. Collins, director of the National Human Genome Research Institute. "Families with a strong history of genetic disease will have one less worry about the circumstances they find themselves in."
However, this is unlikely to put an end to the issue. As genetic tests provide more information more cheaply, the idea of insuring patients against unknown health risks could eventually collapse. One consequence would be a stronger case for universal health coverage. "Ultimately unlocking all these genetic secrets will make the whole idea of private health insurance obsolete,– says Karen Pollitz, director of the Health Policy Institute at Georgetown University." ~ New York Times, May 2
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...